The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection
about
Complement regulation of T-cell alloimmunityBiologics in organ transplantationTherapeutic regulation of complement in patients with renal disease - where is the promise?Effects of complement activation on allograft injuryLate and chronic antibody-mediated rejection: main barrier to long term graft survivalModern approaches to incompatible kidney transplantationThe importance of C4d in biopsies of kidney transplant recipientsTreatment options and strategies for antibody mediated rejection after renal transplantationIssues in solid-organ transplantation in children: translational research from bench to bedside.Antibody-mediated rejection: emergence of animal models to answer clinical questionsImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisThe Complement System and Antibody-Mediated Transplant RejectionGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsBlockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial.Use of monoclonal antibodies in renal transplantation.Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.The use of eculizumab in renal transplantation.Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes.Molecules Great and Small: The Complement System.The role of B cells in solid organ transplantation.Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejectionGuidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Genotypic diversity of complement component C4 does not predict kidney transplant outcomeDiagnosis and management of antibody-mediated rejection: current status and novel approaches.Complement in organ transplantation.Effect of antibodies on endothelium.Antibody-mediated rejection: an evolving entity in heart transplantation.Antibody-mediated rejection in kidney transplantation: a reviewComplement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis.Applying complement therapeutics to rare diseases.Human leukocyte antigen antibody incompatible renal transplantationAntibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology.Successful Salvage Treatment of Resistant Acute Antibody-Mediated Kidney Transplant Rejection with Eculizumab.New immunosuppressive agents in pediatric transplantation.Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.Barriers to successful transplantation of the sensitized patient.Antibody immunosuppressive therapy in solid organ transplant: Part II.Current immunosuppressive treatment after kidney transplantation.Antibody-mediated rejection in kidney transplantation: an update.
P2860
Q26823956-F83C14AD-8E45-45D9-933A-AA753D93DE34Q26829578-B536C60A-75AA-4642-AC55-BB43E983CA5BQ26851705-B0ABC5A4-1464-483E-8947-B2C0A093230AQ26995453-BDF81E02-F08F-4B5C-88BD-16733BA8258DQ27006030-DAFEE1D5-2603-4523-8C0F-601135750399Q27010224-4E3B0BCC-F343-4C55-9E83-800332D59D8AQ27021227-2668BD4D-5DDD-4ED6-82BA-1F01F0896395Q27021397-7DAAD530-BD34-48D9-BCD7-82D275DA7E4CQ27023312-AC1C7390-1B25-4BE3-8701-B06FBB872C02Q27692014-C8FA4B56-0A84-41FF-8CA2-3B6F6C0691FAQ28084366-4B3D8E5F-1B51-4136-9067-B6FA19C85D69Q28087773-0EA03C3C-FE84-4EC7-A106-D128AD2CBB26Q30276550-939237E1-8941-4143-ADB2-6A98D2F2F0FDQ30279164-AE36CA0C-A7D4-4DA8-A8EA-1343C2C099B7Q30491939-0EDDBA18-3831-4466-BA75-568B2CC7F853Q33396236-D3F52726-DA49-43C6-87FF-79F3C781FD07Q33400705-B399FBD1-EAA8-404D-9258-F03F63CE0B5EQ33406570-8DAAEDAE-44D1-492A-8190-1187FC685CF0Q33408360-4E74E19C-9FF0-4FFB-84BD-72436E8E5508Q33419651-0E4D414D-9F6C-48E3-A5C6-FBE9E9E30B28Q33891696-EFDB6AFD-0446-4CE5-BEE0-FC26C752FA0DQ34018912-5819D6FB-C190-4B6E-A65E-DF8C310F222FQ34122035-8A0EE13F-2274-4F0A-A465-266C55592A9DQ34534928-1C2C625E-7FF3-46AD-9ADA-3DEDC9B15509Q34841849-19B03895-2100-44BE-9C2E-CA8F95E119E2Q35001174-8F0523FB-4466-4546-BDED-A89C5120A684Q35547335-5FC12C6C-C050-4812-906E-34F4C4B811A2Q35876250-3FB68F7D-4065-465F-B8D1-C5938C5DB616Q35915453-4395762A-35DA-4447-844B-DD7D832E2947Q36042011-4EB68918-DDBD-4CDB-B994-EC164983ECDAQ36315497-EF6538BB-3EDE-4107-B473-4F78FAACA1A9Q36612789-D4F6B935-CCCB-4F8D-9418-EC46719E7941Q36922103-1028AB01-9FD0-4EAF-9BCD-4AD70D426811Q37200645-8505D3BA-320E-4AB3-9572-77B02278675AQ37446883-EC620C43-9441-427D-AA70-1BEA5E5F92E8Q37660263-850EDEEB-60D0-4E7A-BD60-290818E2C319Q37742103-9AAE156B-50BE-41EA-BFC8-B8017BFCDA9EQ37800331-D9023C7C-5E1F-4559-8A46-7B1E9856E0CBQ37834028-8F4A2079-29C6-4D76-BFEA-C80AB7DC89DEQ37835834-5A1F7E50-4AB6-4482-B86E-146C8A9D6071
P2860
The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The use of antibody to complem ...... re antibody-mediated rejection
@ast
The use of antibody to complem ...... re antibody-mediated rejection
@en
The use of antibody to complem ...... re antibody-mediated rejection
@nl
type
label
The use of antibody to complem ...... re antibody-mediated rejection
@ast
The use of antibody to complem ...... re antibody-mediated rejection
@en
The use of antibody to complem ...... re antibody-mediated rejection
@nl
prefLabel
The use of antibody to complem ...... re antibody-mediated rejection
@ast
The use of antibody to complem ...... re antibody-mediated rejection
@en
The use of antibody to complem ...... re antibody-mediated rejection
@nl
P2093
P3181
P1476
The use of antibody to complem ...... re antibody-mediated rejection
@en
P2093
A A Zachary
A L Singer
A T Hillel
D S Warren
J K Melancon
P3181
P356
10.1111/J.1600-6143.2008.02451.X
P407
P577
2009-01-01T00:00:00Z